Neuro-Oncology
Reviews


Volume 22 Number 4
April 2020


Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 4, April



CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS




GLIOMAS


HIGH-GRADE GLIOMAS


LOW-GRADE GLIOMAS




DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


GLIOBLASTOMA


GLIOSARCOMA




OTHER ASTROCYTIC TUMORS


PILOCYTIC ASTROCYTOMA




EPENDYMAL TUMORS


EPENDYMOMA




OTHER GLIOMAS


CHORDOID GLIOMA OF THE THIRD VENTRICLE




EMBRYONAL TUMORS


MEDULLOBLASTOMA




MESENCHIMAL NON-MENINGOTHELIAL TUMORS


RHABDOMYOSARCOMA




TUMORS OF THE SELLAR REGION


CRANIOPHARINGIOMA




FAMILIAL TUMOR SYNDROMES





CENTRAL NERVOUS SYSTEM TUMORS


Birbrair A (ed).
Tumor Microenvironment. Non-Hematopoietic Cells.
Adv Exp Med Biol, 2020. ISBN 978-3-030-37184-5. Doi 10.1007/978-3-030-37184-5. _




Ho YJ, Li JP, Fan CH, Liu HL, Yeh CK.
Ultrasound in tumor immunotherapy: Current status and future developments.
J Control Release. [2020 Apr 14]. 2020;323:12‐23. Doi 10.1016/j.jconrel.2020.04.023. _




Islam SU, Shehzad A, Ahmed MB, Lee YS.
Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders.
Molecules. 2020 Apr 21. 2020;25(8):E1929. Doi 10.3390/molecules25081929. _




Le Rhun E, Seoane J, Salzet M, Soffietti R, Weller M.
Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system.
Cancer Lett. [2020 Mar 27]. 2020;480:24-28. Doi 10.1016/j.canlet.2020.03.021. _




Majd N, Dasgupta P, de Groot J.
Immunotherapy for Neuro-Oncology.
Adv Exp Med Biol. [2020 Apr 17]. 2020;1244:183-203. Doi 10.1007/978-3-030-41008-7_8. _




Marron JM, Kyi K, Appelbaum PS, Magnuson A.
Medical Decision-Making in Oncology for Patients Lacking Capacity.
Am Soc Clin Oncol Educ Book. 2020 Apr 28. 2020;40:1‐11. Doi 10.1200/EDBK_280279. _


Naing A, Hajjar J (Eds.).
Immunotherapy. Third Edition.
Adv Exp Med Biol. 2020. ISBN 978-3-030-41008-7. Doi:10.1007/978-3-030-41008-7. _


Porfidia A, Giordano M, Sturiale CL, D'Arrigo S, Donadini MP, Olivi A, Ageno W, Pola R.
Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
Brain Behav. [2020 Apr 21]. 2020;e01638. Doi 10.1002/brb3.1638. _


Ramakrishna R, Zadeh G, Sheehan JP, Aghi MK.
Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology.
J Neurooncol. [2020 Apr 9]. 2020;1‐5. Doi 10.1007/s11060-020-03488-7. _



Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Apr 6. Natl Cancer Inst. NBK65913. _


Rosewall T, Feuz C, Bayley A.
Cannabis and Radiation Therapy: A Scoping Review of Human Clinical Trials.
J Med Imaging Radiat Sci. [2020 Apr 2]. 2020;S1939-8654(20)30007-2. doi: 10.1016/j.jmir.2020.01.007. _



Zacharia BE, Eichberg DG, Ivan ME, Hanft S, Boockvar JA, Isildak H, Mansouri A, Komotar RJ, D'Amico RS.
Letter: Surgical Management of Brain Tumor Patients in the COVID-19 Era.
Neurosurgery. [2020 Apr 29]. 2020;nyaa162. Doi 10.1093/neuros/nyaa162. _



GLIOMAS


Fountas KN.
Fluorescent Guided Surgery in the Surgical Management of Glioma: The Dawn of a New Era.
Brain Sci. 2020 Apr 16. 2020;10(4):E237. Doi 10.3390/brainsci10040237. _




Gogos AJ, Young JS, Morshed RA, Hervey-Jumper SL, Berger MS.
Awake glioma surgery: technical evolution and nuances.
J Neurooncol. [2020 Apr 8]. 2020;10.1007/s11060-020-03482-z. doi: 10.1007/s11060-020-03482-z. _




Han S, Liu Y, Cai SJ, Qian M, Ding J, Larion M, Gilbert MR, Yang C.
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets.
Br J Cancer. [2020 Apr 15]. 2020;10.1038/s41416-020-0814-x. doi: 10.1038/s41416-020-0814-x. _




Jang K, Russo C, Di Ieva A.
Radiomics in gliomas: clinical implications of computational modeling and fractal-based analysis.
Neuroradiology. [2020 Apr 6]. 2020;10.1007/s00234-020-02403-1. doi: 10.1007/s00234-020-02403-1. _




Wang Y, Zhao B, Chen W, Liu L, Chen W, Zhou L, Kong Z, Dai C, Wang Y, Ma W.
Pretreatment Geriatric Assessments of Elderly Patients with Glioma: Development and Implications.
Aging Dis. 2020 Mar 9. 2020;11(2):448‐461. doi: 10.14336/AD.2019.0527. _




Zlochower A, Chow DS, Chang P, Khatri D, Boockvar JA, Filippi CG.
Deep Learning AI Applications in the Imaging of Glioma.
Top Magn Reson Imaging. 2020 Apr. 2020;29(2):115-0. Doi 10.1097/RMR.0000000000000237. _



HIGH-GRADE GLIOMAS



Dietz MS, Beach CZ, Barajas R, Parappilly MS, Sengupta SK, Baird LC, Ciporen JN, Han SJ, Loret de Mola R, Cho YJ, Nazemi KJ, McClelland S 3rd, Wong MH, Jaboin JJ.
Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade Gliomas.
Adv Radiat Oncol. 2020 Jan 28. 2020;5(2):152‐162. doi: 10.1016/j.adro.2019.12.008. _




Fuchs Q, Pierrevelcin M, Messe M, Lhermitte B, Blandin AF, Papin C, Coca A, Dontenwill M, Entz-Werlé N.
Hypoxia Inducible Factors' Signaling in Pediatric High-Grade Gliomas: Role, Modelization and Innovative Targeted Approaches.
Cancers (Basel). 2020 Apr 15. 2020;12(4):E979. Doi 10.3390/cancers12040979. _




Gonçalves FG, Alves CAPF, Vossough A.
Updates in Pediatric Malignant Gliomas.
Top Magn Reson Imaging. 2020 Apr. 2020;29(2):83-94. Doi 10.1097/RMR.0000000000000235. _




Han Q, Liang H, Cheng P, Yang H, Zhao P.
Gross Total vs. Subtotal Resection on Survival Outcomes in Elderly Patients With High-Grade Glioma: A Systematic Review and Meta-Analysis.
Front Oncol. 2020 Mar 18. 2020;10:151. Doi 10.3389/fonc.2020.00151. _




Warsi NM, Zewude R, Karmur B, Pirouzmand N, Hachem L, Mansouri A.
The Cost-Effectiveness of 5-ALA in High Grade Glioma Surgery: A Quality-Based Systematic Review.
Can J Neurol Sci. [2020 Apr 24]. 2020;1-17. Doi 10.1017/cjn.2020.78. _



LOW-GRADE GLIOMAS



Cooney T, Yeo KK, Kline C, Prados M, Haas-Kogan D, Chi S, Mueller S.
Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.
Neurooncol Pract. [2019 Aug 13]. 2020;7(1):4-10. Doi 10.1093/nop/npz033. _



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


Andrews C, Prayson RA.
1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma.
Ann Diagn Pathol. [2020 Apr 8]. 2020;46:151519. Doi 10.1016/j.anndiagpath.2020.151519. _




Zhang S, William C.
Educational Case: Histologic and Molecular Features of Diffuse Gliomas.
Acad Pathol. 2020 Apr 3. 2020;7:2374289520914021. Doi 10.1177/2374289520914021. _



GLIOBLASTOMA



Birch JL, Coull BJ, Spender LC, Watt C, Willison A, Syed N, Chalmers AJ, Hossain-Ibrahim MK, Inman GJ.
Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma.
Cell Signal. [2020 Apr 19]. 2020;72:109638. Doi 10.1016/j.cellsig.2020.109638. _




DeOcesano-Pereira C, Machado RAC, Chudzinski-Tavassi AM, Sogayar MC.
Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma.
Int J Mol Sci. 2020 Apr 9. 2020;21(7):2611. doi: 10.3390/ijms21072611. _




Dong Z, Cui H.
The Emerging Roles of RNA Modifications in Glioblastoma.
Cancers (Basel). 2020 Mar 20. 2020;12(3):736. doi: 10.3390/cancers12030736. _




Espiritu AI, Terencio BB, Jamora RDG.
Congenital glioblastoma multiforme with long-term childhood survival: a case report and systematic review.
World Neurosurg. [2020 Apr 13]. 2020;139:90‐96. Doi 10.1016/j.wneu.2020.03.212. _




Garcia CM, Toms SA.
The Role of Circulating MicroRNA in Glioblastoma Liquid Biopsy.
World Neurosurg. [2020 Apr 3]. 2020;138:425‐435. doi: 10.1016/j.wneu.2020.03.128. _




Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL.
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.
Cancer Treat Rev. [2020 Mar 26]. 2020;86:102017. Doi 10.1016/j.ctrv.2020.102017. _




Grégoire H, Roncali L, Rousseau A, Chérel M, Delneste Y, Jeannin P, Hindré F, Garcion E.
Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma.
Front Pharmacol. 2020 Apr 8. 2020;11:368. Doi 10.3389/fphar.2020.00368. _




Kaina B.
Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69.
Biomedicines. 2019 Nov 11. 2019;7(4):90. Doi 10.3390/biomedicines7040090. _
Referring to: Strobel H, et al.,Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines. 2019 Sep 9. 2019;7(3):69. Doi 10.3390/biomedicines7030069. _




Kim G, Ko YT.
Small molecule tyrosine kinase inhibitors in glioblastoma.
Arch Pharm Res. [2020 Apr 1]. 2020;43(4):385‐394. doi: 10.1007/s12272-020-01232-3. _




Laigle-Donadey F, Greffard S.
Management of glioblastomas in the elderly population.
Rev Neurol (Paris). [2020 Apr 16]. 2020;S0035-3787(20)30513-0. Doi 10.1016/j.neurol.2020.01.362. _




Medikonda R, Dunn G, Rahman M, Fecci P, Lim M.
A review of glioblastoma immunotherapy.
J Neurooncol. [2020 Apr 6]. 2020;10.1007/s11060-020-03448-1. doi: 10.1007/s11060-020-03448-1. _




Patterson JD, Wongsurawat T, Rodriguez A.
A Glioblastoma Genomics Primer for Clinicians.
Med Res Arch. 2020 Feb 21. 2020;8(2):10.18103/mra.v8i2.2034. Doi 10.18103/mra.v8i2.2034. _




Pottoo FH, Javed N, Rahman J, Abu-Izneid T, Khan FA.
Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme.
Semin Cancer Biol. [2020 Apr 14]. 2020;S1044-579X(20)30084-5. Doi 10.1016/j.semcancer.2020.04.001. _




Rajaratnam V, Islam MM, Yang M, Slaby R, Ramirez HM, Mirza SP.
Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments.
Cancers (Basel). 2020 Apr 10. 2020;12(4):E937. doi: 10.3390/cancers12040937. _




Ranjan S, Skorupan N, Ye X, Sivakumar A, Yankulina O, Kamson D, Grossman SA, Dzaye O, Holdhoff M.
Patterns of bevacizumab use in patients with glioblastoma: an online survey among experts in neuro-oncology.
Neurooncol Pract. [2019 Jul 6]. 2020;7(1):52-58. Doi 10.1093/nop/npz022. _




Sanders S, Debinski W.
Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma.
Int J Mol Sci. 2020 Apr 16. 2020;21(8):E2759. Doi 10.3390/ijms21082759. _




Tan LQ, Nagaputra JC, Soh SY, Ng LP, Low DCY, Low SYY.
Extraneural metastatic paediatric glioblastoma: Case report and literature review.
J Clin Neurosci. [2020 Apr 9]. 2020;S0967-5868(20)30141-7. Doi 10.1016/j.jocn.2020.04.004. _




Wen PY, Weller M, Lee EQ, Alexander BA, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA, Cloughesy TF, DeGroot JF, Galanis E, Gilbert MR, Hegi ME, Horbinski C, Huang RY, Lassman AB, Le Rhun E, Lim M, Mehta MP, Mellinghoff IK, Minniti G, Nathanson D, Platten M, Preusser M, Roth P, Sanson M, Schiff D, Short SC, Taphoorn MJB, Tonn JC, Tsang J, Verhaak RGW, von Deimling A, Wick W, Zadeh G, Reardon DA, Aldape KD, van den Bent MJ.
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions.
Neuro Oncol. [2020 Apr 24]. 2020;noaa106. Doi 10.1093/neuonc/noaa106. _




Weenink B, French PJ, Sillevis Smitt PAE, Debets R, Geurts M.
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives.
Cancers (Basel). 2020 Mar 22. 2020;12(3):751. Doi 10.3390/cancers12030751. _




Westhoff MA, Baisch T, Herbener VJ, Karpel-Massler G, Debatin KM, Strobel H.
Comment in Response to "Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina".
Biomedicines. 2020 Apr 20. 2020;8(4):E93. Doi 10.3390/biomedicines8040093. _
Referring to: Kaina B.,Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy. Comment on Strobel et al., Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 2019, 7, 69. Biomedicines. 2019 Nov 11. 2019;7(4):90. Doi 10.3390/biomedicines7040090. _
In turn Referring to: Strobel H, et al.,Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines. 2019 Sep 9. 2019;7(3):69. Doi 10.3390/biomedicines7030069. _




Yan C, Kong X, Gong S, Liu F, Zhao Y.
Recent advances of the regulation roles of MicroRNA in glioblastoma.
Int J Clin Oncol. [2020 Apr 29]. 2020;10.1007/s10147-020-01685-y. Doi 10.1007/s10147-020-01685-y. _



GLIOSARCOMA



Awadalla AS, Al Essa AM, Al Ahmadi HH, Al Ojan A, Muazen Y, Alsayyah A, Alsaif H, Alsafwani NS.
Gliosarcoma case report and review of the literature.
Pan Afr Med J. 2019 Jun 27. 2019;20:914-919. Doi 10.12659/AJCR.916020. _



OTHER ASTROCYTIC TUMORS



PILOCYTIC ASTROCYTOMA



Adib SD, Schuhmann MU, Hempel JM, Bornemann A, Zamora RE, Tatagiba M.
Surgical management of primary and secondary pilocytic astrocytoma of the cerebellopontine angle (in adults and children) and review of the literature.
Neurosurg Rev. [2020 Apr 15]. 2020;10.1007/s10143-020-01293-4. Doi 10.1007/s10143-020-01293-4. _




Tjota MY, Pytel P.
Educational Case: Pilocytic Astrocytoma With Atypical Features.
Acad Pathol. 2020 Mar 30. 2020;7:2374289520912498. Doi 10.1177/2374289520912498. _



EPENDYMAL TUMORS



EPENDYMOMA



Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Ependymoma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Apr 6. Natl Cancer Inst. NBK65742. _



OTHER GLIOMAS



CHORDOID GLIOMA OF THE THIRD VENTRICLE



Chen X, Zhang B, Pan S, Sun Q, Bian L.
ChorDoid Glioma of the Third Ventricle: A Case Report and a Treatment Strategy to This Rare Tumor.
Front Oncol. 2020 Apr 9. 2020;10:502. Doi 10.3389/fonc.2020.00502. _



EMBRYONAL TUMORS



MEDULLOBLASTOMA



Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Mar 23. Natl Cancer Inst. NBK65981. _




Donovan LK, Delaidelli A, Joseph SK, Bielamowicz K, Fousek K, Holgado BL, Manno A, Srikanthan D, Gad AZ, Van Ommeren R, Przelicki D, Richman C, Ramaswamy V, Daniels C, Pallota JG, Douglas T, Joynt ACM, Haapasalo J, Nor C, VlaDoi:u MC, Kuzan-Fischer CM, Garzia L, Mack SC, Varadharajan S, Baker ML, Hendrikse L, Ly M, Kharas K, Balin P, Wu X, Qin L, Huang N, Stucklin AG, Morrissy AS, Cavalli FMG, Luu B, Suarez R, De Antonellis P, Michealraj A, Rastan A, Hegde M, Komosa M, Sirbu O, Kumar SA, Abdullaev Z, Faria CC, Yip S, Hukin J, Tabori U, Hawkins C, Aldape K, Daugaard M, Maris JM, Sorensen PH, Ahmed N, Taylor MD.
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma.
Nat Med. [2020 Apr 27]. 2020;26(5):720‐731. Doi 10.1038/s41591-020-0827-2. _




Ellison DW.
Mini-Symposium in Medulloblastoma Genomics in the Modern Molecular Era.
Brain Pathol. [2020 Apr 3]. 2020;30(3):661‐663. Doi 10.1111/bpa.12838. _




Guerrini-Rousseau L, Abbas R, Huybrechts S, Kieffer-Renaux V, Puget S, Andreiuolo F, Beccaria K, Blauwblomme T, Bolle S, Dhermain F, Longaud A, Roujeau T, Sainte-Rose C, Tauziede-Esperiat A, Varlet P, Zerah M, Valteau-Couanet D, Dufour C, Grill J.
Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children.
Neuro Oncol. [2020 Apr 8]. 2020;noaa083. Doi 10.1093/neuonc/noaa083. _




Ma AK, Freedman I, Lee JH, Miyagishima D, Ahmed O, Yeung J.
Tumor Location and Treatment Modality are Associated with Overall Survival in Adult Medulloblastoma.
Cureus. 2020 Feb 20. 2020;12(2):e7061. Doi 10.7759/cureus.7061. _




Orr BA.
Pathology, Diagnostics, and Classification of Medulloblastoma.
Brain Pathol. [2020 Apr 2]. 2020;30(3):664‐678. Doi: 10.1111/bpa.12837. _



MESENCHIMAL NON-MENINGOTHELIAL TUMORS



RHABDOMYOSARCOMA



Mallereau CH, Ganau M, Todeschi J, Cebula H, Santin MD, Virbel G, Pop R, Lhermitte B, Proust F, Chibbaro S.
Primary Brain Rhabdomyosarcoma Causing Extracranial Metastases: Case Report with Narrative Review of Atypical Presentations and Their Diagnostic Challenges.
World Neurosurg. [2020 Mar 27]. 2020;138:363‐368. Doi 10.1016/j.wneu.2020.03.110. _



TUMORS OF THE SELLAR REGION



CRANIOPHARINGIOMA



Ritchey AK et al, PDQ Pediatric Treatment Editorial Board.
Childhood Craniopharyngioma Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Apr 2. Natl Cancer Inst. NBK65796. _



FAMILIAL TUMOR SYNDROMES


Libert DM, Prayson RA.
Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.
Ann Diagn Pathol. [2020 Apr 13]. 2020;46:151516. Doi 10.1016/j.anndiagpath.2020.151516. _




Yao L, Alahmari M, Temel Y, Hovinga K.
Therapy of Sporadic and NF2-Related Vestibular Schwannoma.
Cancers (Basel). 2020 Mar 31. 2020;12(4):E835. Doi 10.3390/cancers12040835. _



bottom